Finance

Beta
Lists
NXTC:NASDAQ
NextCure Inc
$1.70
-2.85%
(-0.050) 1D
Jun 30, 1:34:52 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
$1.76
High
$1.90
Low
$1.70
Mkt. cap
6.12M
Avg. vol.
136.38K
Volume
89.45K
52-wk high
$15.74
52-wk low
$1.55
EPS
-$18.75
Beta
1.30
Shares outstanding
3.61M
No. of employees
40
Open
$1.76
High
$1.90
Low
$1.70
Mkt. cap
6.12M
Avg. vol.
136.38K
Volume
89.45K
52-wk high
$15.74
52-wk low
$1.55
EPS
-$18.75
Beta
1.30
Shares outstanding
3.61M
No. of employees
40
News stories
From sources across the web
About NextCure Inc
CEO-
Employees40
Founded2015
Headquarters-
SectorBiotechnology
Websitenextcure.com
Analyst ratings
Based on 2 analysts giving stock ratings to NXTC in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NXTC in the last 3 months.
Highest
Current $1.70
$25.00 (+1,370.50%)
Average
$20.00 (+1,076.40%)
Lowest
$15.00 (+782.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Tenthoff
Piper Sandler
Buy
Maintained
$15.00
+782.3%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$25.00
+1,370.5%
06/02/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$20.00
+1,076.4%
11/17/2025
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Upgraded
$18.00
+958.8%
11/07/2025
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.87 / -$1.84
-1.36%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
24.09M
6.14M
6.80M
6.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20M
2.81M
2.96M
3.27M
Operating expense
27.29M
8.94M
9.76M
10.10M
Total operating expenses
27.29M
8.94M
9.76M
10.10M
Operating income
-27.29M
-8.94M
-9.76M
-10.10M
Other non operating income
-
-
-
-
EBT including unusual items
-26.81M
-8.62M
-9.44M
-9.80M
EBT excluding unusual items
-26.81M
-8.62M
-9.44M
-9.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.81M
-8.62M
-9.44M
-9.80M
Net profit margin
-
-
-
-
Earnings per share
-11.29
-3.22
-0.81
-1.87
Interest and investment income
484.00K
321.00K
321.00K
309.00K
Interest expense
-
-
-
-
Net interest expenses
484.00K
321.00K
321.00K
309.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.66M
-8.41M
-9.39M
-9.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer